Therefore, the above results partially suggest the clinical effect of the miR-16 family /TFAP2A/PSG9 axis upon LUAD, especially for lymph node metastasis, and relative to miR-195/424, miR-16/497 signals might be more significant. The gene discussed is PSG9; the disease is metastatic malignant neoplasm in the lymph nodes.